Ligand-based tools are characterized by their speed but do not take into account the receptor while structure-based tools model ligand-receptor interactions but are more compute intensive.

It has been shown that in many projects simpler approaches work better, which might seem counterintuitive, but this is due to the noise introduced by complex models.

What do you think?

The post Ligand-based or structure-based virtual screening? appeared first on Pharmacelera | Pushing the limits of computational chemistry.